Alvogen's vision

Alvogen has an intrinsic passion for performance and growth and has become a major driver of change in this fast-evolving industry. Alvogen's team is passionately committed to continuing to grow the business around the world and to cement the company's position as a global player in generics.

A unique portfolio of high-quality and challenging-to-make pharmaceutical products fuels the company's targeted growth strategy.

By 2025 this strategy will have inspired Alvogen to become a leading global generic pharmaceutical company and a preferred partner committed to making a meaningful difference in the lives of the millions of people it serves worldwide.

“Our vision is to become the preferred partner in generics by setting the new standard for the future of the industry.”

Róbert Wessman, CEO of Alvogen

The world is changing fast and traditional generics businesses are being challenged like never before. Alvogen is ready to react swiftly to this changing environment and tough competition in order to better serve patients globally.

Alvogen is committed to becoming the preferred partner in all markets, through the clear vision of development and growth outlined in its strategic roadmap: The Alvogen STARMAP.

The Alvogen STARMAP


We focus on building a targeted and profitable portfolio in all our markets to serve our customers best.

02 - Quality

We are committed to the highest quality standards for all our products and services.

03 - Service

We have a relentless focus on providing consistent and reliable high-quality service to our customers.

04 - People

We select, recruit and retain the best talent in every field to fuel our success through our performance-driven culture.

05 - Cost

We are a lean global organization with a constant focus on operational efficiency and cost.